Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.1400 (31.11%)
May 26, 2026, 9:30 AM EST
Orgenesis Revenue
In the year 2024, Orgenesis had annual revenue of $1.04M with 95.28% growth. Orgenesis had revenue of $347.00K in the quarter ending September 30, 2024, with 215.45% growth.
Revenue
1.04M
Revenue Growth
+95.28%
P/S Ratio
4.26
Revenue / Employee
13.44K
Employees
77
Market Cap
4.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.04M | 505.00K | 95.28% |
| Dec 31, 2023 | 530.00K | -35.50M | -98.53% |
| Dec 31, 2022 | 36.03M | 523.00K | 1.47% |
| Dec 31, 2021 | 35.50M | 27.85M | 363.96% |
| Dec 31, 2020 | 7.65M | 3.75M | 96.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Vaccinex | 601.00K |
| Iterum Therapeutics | 390.00K |
| GPL Holdings | 376.54K |
| Eastgate Biotech | 137.64K |
| Enzolytics | 46.59K |
Orgenesis News
- 7 days ago - Orgenesis Proxy statement: Proxy filing - Filings
- 22 days ago - Orgenesis Proxy statement: Proxy filing - Filings
- 5 weeks ago - Orgenesis Proxy statement: Proxy filing - Filings
- 2 months ago - Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - Newsfile Corp
- 2 months ago - Orgenesis Annual report: Q4 2024 - Filings
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis secures $5M equity investment from Williamsburg Venture - TheFly
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire